The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Abstract
OBJECTIVE: Methamphetamine is a popular and highly addictive drug of abuse that has raised concerns because it has been shown in laboratory animals to be neurotoxic to dopamine terminals. The authors evaluated if similar changes occur in humans and assessed if they were functionally significant. METHOD: Positron emission tomography scans following administration of [(11)C]d-threo-methylphenidate (a dopamine transporter ligand) measured dopamine transporter levels (a marker of dopamine cell terminals) in the brains of 15 detoxified methamphetamine abusers and 18 comparison subjects. Neuropsychological tests were also performed to assess motor and cognitive function. RESULTS: Methamphetamine abusers showed significant dopamine transporter reduction in the striatum (mean differences of 27.8% in the caudate and 21.1% in the putamen) relative to the comparison subjects; this reduction was evident even in abusers who had been detoxified for at least 11 months. Dopamine transporter reduction was associated with motor slowing and memory impairment. CONCLUSIONS: These results provide evidence that methamphetamine at dose levels taken by human abusers of the drug leads to dopamine transporter reduction that is associated with motor and cognitive impairment. These results emphasize the urgency of alerting clinicians and the public of the long-term changes that methamphetamine can induce in the human brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,479
Self-citationStriatal dopamine nerve terminal markers in human, chronic methamphetamine users
Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., Schmunk, G. A., Shannak, K., Haycock, J. W., & Kish, S. J. (1996) · Nature Medicine · doi:10.1038/nm0696-699 · Cited by 718
McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08417.1998 · Cited by 602
Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
Ricaurte, G. A., Guillery, R. W., Seiden, L. S., Schuster, C. R., & Moore, R. Y. (1982) · Brain Research · doi:10.1016/0006-8993(82)90198-6 · Cited by 479
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
Vingerhoets, F. J. G., Schulzer, M., Calne, D. B., & Snow, B. J. (1997) · Annals of Neurology · doi:10.1002/ana.410410111 · Cited by 359
Innis, R. B., Seibyl, J. P., Scanley, B. E., Laruelle, M., Abi-Dargham, A., Wallace, E., Baldwin, R. M., Zea-Ponce, Y., Zoghbi, S., & Wang, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11965 · Cited by 359
Frost, J. J., Rosier, A. J., Reich, S. G., Smith, J. S., Ehlers, M. D., Snyder, S. H., Ravert, H. T., & Dannals, R. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340331 · Cited by 320
Maggio, R., Riva, M., Vaglini, F., Fornai, F., Molteni, R., Armogida, M., Racagni, G., & Corsini, G. U. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062439.x · Cited by 218
Villemagne, V., Yuan, J., Wong, D. F., Dannals, R. F., Hatzidimitriou, G., Mathews, W. B., Ravert, H. T., Musachio, J., McCann, U. D., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00419.1998 · Cited by 211
Immunochemical analysis of dopamine transporter protein in Parkinson's disease
Miller, G. W., Staley, J. K., Heilman, C. J., Perez, J. T., Mash, D. C., Rye, D. B., & Levey, A. I. (1997) · Annals of Neurology · doi:10.1002/ana.410410417 · Cited by 200
Marié, R. M., Barré, L., Dupuy, B., Viader, F., Defer, G., & Baron, J. C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00928-8 · Cited by 177
Neurophysiology and cognitive functions of the striatum.
Rolls, E. T. (1994) · PubMed · Cited by 167
Logan, J., Volkow, N. D., Fowler, J. S., Wang, G.-J., Dewey, S. L., MacGregor, R., Schlyer, D., Gatley, S. J., Pappas, N., King, P., et al. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.132 · Cited by 167
Self-citationSeiden, L. S., US Department of Health and Human Services; National Institute on Drug Abuse, & Sabol, K. E. (1996) · PsycEXTRA Dataset · doi:10.1037/e495672006-014 · Cited by 166
Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.
Asenbaum, S., Brücke, T., Pirker, W., Podreka, I., Angelberger, P., Wenger, S., Wöber, C., Müller, F. M., & Deecke, L. (1997) · PubMed · Cited by 163
Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice
Itoh, J., Nabeshima, T., & Kameyama, T. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90125-a · Cited by 160
Melega, W. P., Raleigh, M. J., Stout, D. B., Laćan, G., Huang, S.-C., & Phelps, M. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00548-9 · Cited by 126
Wallace, T. L., Gudelsky, G. A., & Vorhees, C. V. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-20-09141.1999 · Cited by 125
A new PET ligand for the dopamine transporter: studies in the human brain.
Volkow, N. D., Ding, Y., Fowler, J. S., Wang, G., Logan, J., Gatley, S. J., Schlyer, D. J., & Pappas, N. R. (1995) · PubMed · Cited by 120
Self-citationWoolverton, W. L., Cervo, L., & Johanson, C. E. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(84)80012-x · Cited by 113
Rinne, J. O., Ruottinen, H., Bergman, J., Haaparanta‐Solin, M., Sonninen, P. H., & Solin, O. H. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.6.737 · Cited by 94
Cognitive concomitants of dopamine system stimulation in parkinsonian patients.
Mohr, E., Fabbrini, G., Ruggieri, S. A., Fedio, P., & Chase, T. N. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.9.1192 · Cited by 65
Human Methamphetamine-Related Fatalities in Taiwan During 1991–1996
Shaw, K.-P. (1999) · Journal of Forensic Sciences · doi:10.1520/jfs14408j · Cited by 61
PET studies of parkinsonism associated with mutation in the α-synuclein gene
Samii, A., Markopoulou, K., Wszołek, Z. K., Sossi, V., Dobko, T., Mak, E., Calne, D. B., & Stoessl, A. J. (1999) · Neurology · doi:10.1212/wnl.53.9.2097 · Cited by 60
Bendriem, B., Dewey, S. L., Schlyer, D. J., Wolf, A. P., & Volkow, N. D. (1991) · IEEE Transactions on Medical Imaging · doi:10.1109/42.79480 · Cited by 45
Self-citationTraffic and Illegal Production of Drugs in Rural America
O'Dea, P. J., Murphy, B., & Balzer, C. (1997) · PsycEXTRA Dataset · doi:10.1037/e495612006-006 · Cited by 25
Cited by
Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667
Self-citationThe mysterious motivational functions of mesolimbic dopamine
Salamone, J. D., & Correa, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.10.021 · Cited by 1,418
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001507 · Cited by 1,101
Self-citationEffort-related functions of nucleus accumbens dopamine and associated forebrain circuits
Salamone, J. D., Correa, M., Farrar, A., & Mingote, S. M. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0668-9 · Cited by 1,000
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
Self-citation
Metadata
- Authors
- Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., Logan, J., Wong, C., & Miller, E. N.
- Venue
- American Journal of Psychiatry
- Published
- 2001-03-01
- Volume
- 158
- Issue
- 3
- Pages
- 377-382
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2163320407
- Cited by
- 984
- References
- 27
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.